Update on the European Respiratory Review

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 993-994

  Humbert, M ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HELIOX;

ALTITUDE DISEASE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EDITORIAL; EXERCISE; FIBROSING ALVEOLITIS; HUMAN; LUNG EMBOLISM; LUNG GRANULOMA; LUNG INFECTION; LUNG NON SMALL CELL CANCER; LUNG TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; RESPIRATORY TRACT DISEASE; SLEEP DISORDERED BREATHING; VENOUS THROMBOEMBOLISM;

EUROPE; HUMANS; LUNG DISEASES; PERIODICALS AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 78349235465     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00134210     Document Type: Editorial

References (21)

1. Humbert M. Introducing the new European Respiratory Review. Eur Respir J 2009; 33: 466-467.
2. Souza R, Jardim C. Trends in pulmonary arterial hypertension. Eur Respir Rev 2009; 18: 7-12.
3. Xu W-Q, Jing Z-C. High-altitude pulmonary hypertension. Eur Respir Rev 2009; 18: 13-17.
4. Beghetti M. Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs. Eur Respir Rev 2009; 18: 18-23.
5. Lang IM. Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options. Eur Respir Rev 2009; 18: 24-28.
6. Olschewski H. Inhaled iloprost for the treatment of pulmonary hypertension. Eur Respir Rev 2009; 18: 29-34.
7. Ghofrani HA, Grimminger F. Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy. Eur Respir Rev 2009; 18: 35-41.
8. Gaga M, Zervas E, Chanez P. Update on severe asthma: what we know and what we need. Eur Respir Rev 2009; 18: 58-65.
9. Burgel P-R, de Blic J, Chanez P, et al. Update on the roles of distal airways in asthma. Eur Respir Rev 2009; 18: 80-95.
10. Demoly P, Paggiaro P, Plaza V, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009; 18: 105-112.
11. Sanchez O, Planquette B, Meyer G. Update on acute pulmonary embolism. Eur Respir Rev 2009; 18: 137-147.
12. Bourdin A, Burgel P-R, Chanez P, et al. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev 2009; 18: 198-212.
13. Alifano M, Cuvelier A, Delage A, et al. Treatment of COPD: from pharmacological to instrumental therapies. Eur Respir Rev 2010; 19: 7-23.
14. Raherison C, Girodet P-O. Epidemiology of COPD. Eur Respir Rev 2009; 18: 213-221.
15. Hunt T, Williams MT, Frith P, et al. Heliox, dyspnoea and exercise in COPD. Eur Respir Rev 2010; 19: 30-38.
16. Troosters T, Gosselink R, Janssens W, et al. Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur Respir Rev 2010; 19: 24-29.
17. Harari S, Caminati A. Update on diffuse parenchymal lung disease. Eur Respir Rev 2010; 19: 97-108.
18. Zalcman G, Bergot E, Lechapt E. Update on nonsmall cell lung cancer. Eur Respir Rev 2010; 19: 173-185.
19. Armour AA, Watkins CL. The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer. Eur Respir Rev 2010; 19: 186-196.
20. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
21. Montani D, O'Callaghan DS, Jaïs X, et al. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev 2009; 18: 272-290.